感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

2020 NICE指南：COVID-19快速指南—肾移植（NG.178）

2020-06-19 英国国家卫生与临床优化研究所 NICE官网

肾移植 COVID-19

2020年6月，英国国家卫生与临床优化研究所 (NICE)发布了COVID-19快速指南之肾移植部分。文章涵盖了儿童，青少年和成人需要进行肾移植患者以及肾脏捐赠者在COVID‑19流行期间需要的注意

中文标题：

2020 NICE指南：COVID-19快速指南—肾移植（NG.178）

英文标题：

NICE guideline [NG178]：COVID 19 rapid guideline: renal transplantation

发布机构：

英国国家卫生与临床优化研究所

发布日期：

2020-06-19

简要介绍：

2020年6月，英国国家卫生与临床优化研究所 (NICE)发布了COVID-19快速指南之肾移植部分。文章涵盖了儿童，青少年和成人需要进行肾移植患者以及肾脏捐赠者在COVID‑19流行期间需要的注意事项。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 NICE指南：COVID-19快速指南—肾移植（NG.178.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9066c1c00193a519, title=2020 NICE指南：COVID-19快速指南—肾移植（NG.178）, enTitle=NICE guideline [NG178]：COVID 19 rapid guideline: renal transplantation, guiderFrom=NICE官网, authorId=0, author=, summary=2020年6月，英国国家卫生与临床优化研究所 (NICE)发布了COVID-19快速指南之肾移植部分。文章涵盖了儿童，青少年和成人需要进行肾移植患者以及肾脏捐赠者在COVID‑19流行期间需要的注意, cover=https://img.medsci.cn/2020714/1594659824693_2020535.jpg, journalId=0, articlesId=null, associationId=85, associationName=英国国家卫生与临床优化研究所, associationIntro=英国国家卫生与临床优化研究所（NICE，National Institute for Health and Clinical Excellence）是NHS的组织，设在伦敦和曼彻斯特。NICE成立于1999年4月1日，目标是确保每个英格兰和威尔士人平等享有NHS医疗的机会。NICE制定指南，设定质量标准，管理国家数据库，为NHS、当地权威部门和其他组织提供指南。, copyright=0, guiderPublishedTime=Fri Jun 19 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年6月，英国国家卫生与临床优化研究所 (NICE)发布了COVID-19快速指南之肾移植部分。文章涵盖了儿童，青少年和成人需要进行肾移植患者以及肾脏捐赠者在COVID‑19流行期间需要的注意事项。</p> </div> </div> </div>, tagList=[TagDto(tagId=261, tagName=肾移植), TagDto(tagId=102190, tagName= COVID-19)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=102190, guiderKeyword= COVID-19, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=5, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3665, appHits=133, showAppHits=0, pcHits=715, showPcHits=3532, likes=3, shares=12, comments=10, approvalStatus=1, publishedTime=Tue Jul 14 01:17:13 CST 2020, publishedTimeString=2020-06-19, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Jul 14 01:04:01 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 10:19:48 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 NICE指南：COVID-19快速指南—肾移植（NG.178.pdf)])
2020 NICE指南：COVID-19快速指南—肾移植（NG.178.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1069485, encodeId=d21e1069485fd, content=可以规范化管理了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24d05619594, createdName=ms3000000366766127, createdTime=Fri Nov 12 08:59:26 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950056, encodeId=15d0950056dd, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210322/61a71434e1764160b4cd9baee94e7a55/eee5c1c1e8a54e4bb58dbcf51dbb31f0.jpg, createdBy=eb4d1856368, createdName=ms9056046557664914, createdTime=Mon Mar 22 09:45:48 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918429, encodeId=22e291842932, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d16d2458443, createdName=124105e0m30暂无昵称, createdTime=Wed Jan 20 15:32:32 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890283, encodeId=d2aa8902830d, content=及时雨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5595414287, createdName=ms5000000759415090, createdTime=Mon Oct 05 22:14:22 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810316, encodeId=ff1b810316fa, content=。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70515130105, createdName=146541bem82暂无昵称, createdTime=Tue Aug 18 15:30:01 CST 2020, time=2020-08-18, status=1, ipAttribution=)]
    2021-11-12 ms3000000366766127

    可以规范化管理了#学习#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1069485, encodeId=d21e1069485fd, content=可以规范化管理了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24d05619594, createdName=ms3000000366766127, createdTime=Fri Nov 12 08:59:26 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950056, encodeId=15d0950056dd, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210322/61a71434e1764160b4cd9baee94e7a55/eee5c1c1e8a54e4bb58dbcf51dbb31f0.jpg, createdBy=eb4d1856368, createdName=ms9056046557664914, createdTime=Mon Mar 22 09:45:48 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918429, encodeId=22e291842932, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d16d2458443, createdName=124105e0m30暂无昵称, createdTime=Wed Jan 20 15:32:32 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890283, encodeId=d2aa8902830d, content=及时雨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5595414287, createdName=ms5000000759415090, createdTime=Mon Oct 05 22:14:22 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810316, encodeId=ff1b810316fa, content=。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70515130105, createdName=146541bem82暂无昵称, createdTime=Tue Aug 18 15:30:01 CST 2020, time=2020-08-18, status=1, ipAttribution=)]
    2021-03-22 ms9056046557664914

    受益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1069485, encodeId=d21e1069485fd, content=可以规范化管理了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24d05619594, createdName=ms3000000366766127, createdTime=Fri Nov 12 08:59:26 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950056, encodeId=15d0950056dd, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210322/61a71434e1764160b4cd9baee94e7a55/eee5c1c1e8a54e4bb58dbcf51dbb31f0.jpg, createdBy=eb4d1856368, createdName=ms9056046557664914, createdTime=Mon Mar 22 09:45:48 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918429, encodeId=22e291842932, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d16d2458443, createdName=124105e0m30暂无昵称, createdTime=Wed Jan 20 15:32:32 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890283, encodeId=d2aa8902830d, content=及时雨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5595414287, createdName=ms5000000759415090, createdTime=Mon Oct 05 22:14:22 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810316, encodeId=ff1b810316fa, content=。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70515130105, createdName=146541bem82暂无昵称, createdTime=Tue Aug 18 15:30:01 CST 2020, time=2020-08-18, status=1, ipAttribution=)]
    2021-01-20 124105e0m30暂无昵称

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1069485, encodeId=d21e1069485fd, content=可以规范化管理了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24d05619594, createdName=ms3000000366766127, createdTime=Fri Nov 12 08:59:26 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950056, encodeId=15d0950056dd, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210322/61a71434e1764160b4cd9baee94e7a55/eee5c1c1e8a54e4bb58dbcf51dbb31f0.jpg, createdBy=eb4d1856368, createdName=ms9056046557664914, createdTime=Mon Mar 22 09:45:48 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918429, encodeId=22e291842932, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d16d2458443, createdName=124105e0m30暂无昵称, createdTime=Wed Jan 20 15:32:32 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890283, encodeId=d2aa8902830d, content=及时雨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5595414287, createdName=ms5000000759415090, createdTime=Mon Oct 05 22:14:22 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810316, encodeId=ff1b810316fa, content=。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70515130105, createdName=146541bem82暂无昵称, createdTime=Tue Aug 18 15:30:01 CST 2020, time=2020-08-18, status=1, ipAttribution=)]
    2020-10-05 ms5000000759415090

    及时雨

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1069485, encodeId=d21e1069485fd, content=可以规范化管理了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24d05619594, createdName=ms3000000366766127, createdTime=Fri Nov 12 08:59:26 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950056, encodeId=15d0950056dd, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210322/61a71434e1764160b4cd9baee94e7a55/eee5c1c1e8a54e4bb58dbcf51dbb31f0.jpg, createdBy=eb4d1856368, createdName=ms9056046557664914, createdTime=Mon Mar 22 09:45:48 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918429, encodeId=22e291842932, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d16d2458443, createdName=124105e0m30暂无昵称, createdTime=Wed Jan 20 15:32:32 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890283, encodeId=d2aa8902830d, content=及时雨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5595414287, createdName=ms5000000759415090, createdTime=Mon Oct 05 22:14:22 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810316, encodeId=ff1b810316fa, content=。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70515130105, createdName=146541bem82暂无昵称, createdTime=Tue Aug 18 15:30:01 CST 2020, time=2020-08-18, status=1, ipAttribution=)]
    2020-08-18 146541bem82暂无昵称

    。。

    0

相关指南

2020 KDIGO临床实践指南：肾脏移植候选者的评估和管理—肾脏疾病

改善全球肾脏病预后组织(KDIGO,Kidney Disease: Improving Global Outcomes) · 2020-04-01

肾移植术后随访规范（2019版）

中华医学会器官移植学分会 · 2019-11-01

肾移植术后移植物功能延迟恢复诊疗技术规范（2019版）

中华医学会器官移植学分会 · 2019-09-15

肾移植排斥反应临床诊疗技术规范（2019版）

中华医学会器官移植学分会 · 2019-09-15

肾移植围手术期处理操作规范（2019版）

中华医学会器官移植学分会 · 2019-09-15

中国肾移植术后高尿酸血症诊疗技术规范（2019版）

中华医学会器官移植学分会 · 2019-01-15

拓展阅读

2020 ESE声明：COVID-19和内分泌疾病

欧洲内分泌学会(ESE,European Society of Endocrinology) · 2020-04-11

2020 韩国COVID-19实验室诊断指南

韩国检验医学学会(KSLM,Korean Society for Laboratory Medicine) · 2020-04-20

2020 ESGE/ESGENA立场声明：胃肠内镜检查和COVID-19流行

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2020-04-17

2020 IDSA指南：COVID-19患者的治疗和管理

美国感染病学会(IDSA,Infectious Diseases Society of America) · 2020-04-27

2020 国际专家小组实践声明：COVID-19流行期间支气管镜检查

国外呼吸科专家组（统称） · 2020-04-28

2020 ESTRO/ASTRO共识声明：COVID-19流行期间肺癌的放疗建议

欧洲放射肿瘤学学会(ESTRO,European Society of Radiotherapy & Oncology) · 2020-04-06